Total Payments
$1,632
2024 Payments
$59.98
Companies
13
Transactions
79
Medicare Patients
52
Medicare Billing
$2,563
Payment Breakdown by Category
Food & Beverage$1,632 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,632 | 79 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $408.26 | 22 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $330.48 | 13 | $0 (2024) |
| Neos Therapeutics, LP | $237.09 | 12 | $0 (2020) |
| Supernus Pharmaceuticals, Inc. | $147.94 | 6 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $115.89 | 7 | $0 (2019) |
| Shire North American Group Inc | $95.59 | 5 | $0 (2018) |
| Lundbeck LLC | $83.71 | 4 | $0 (2022) |
| Allergan Inc. | $74.69 | 4 | $0 (2018) |
| AbbVie Inc. | $44.66 | 2 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $27.65 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59.98 | 1 | Janssen Pharmaceuticals, Inc ($59.98) |
| 2023 | $118.50 | 5 | Supernus Pharmaceuticals, Inc. ($64.26) |
| 2022 | $241.33 | 10 | Supernus Pharmaceuticals, Inc. ($83.68) |
| 2021 | $383.20 | 18 | Takeda Pharmaceuticals U.S.A., Inc. ($226.85) |
| 2020 | $199.30 | 10 | Takeda Pharmaceuticals U.S.A., Inc. ($77.93) |
| 2019 | $237.79 | 15 | Sunovion Pharmaceuticals Inc. ($68.73) |
| 2018 | $121.49 | 6 | Sunovion Pharmaceuticals Inc. ($47.16) |
| 2017 | $270.73 | 14 | Neos Therapeutics, LP ($132.95) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/26/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $59.98 | General |
| Category: Neuroscience | ||||||
| 05/01/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: PSYCHIATRY | ||||||
| 03/16/2023 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $29.64 | General |
| 01/20/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $19.93 | General |
| Category: PSYCHOLOGY | ||||||
| 01/20/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.69 | General |
| Category: PSYCHOLOGY | ||||||
| 01/06/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.93 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $33.98 | General |
| Category: PSYCHOLOGY | ||||||
| 10/28/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $15.72 | General |
| Category: PSYCHOLOGY | ||||||
| 10/21/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: Neuroscience | ||||||
| 10/07/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.42 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $33.98 | General |
| Category: PSYCHOLOGY | ||||||
| 07/29/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Neuroscience | ||||||
| 04/29/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: NEUROSCIENCE | ||||||
| 02/04/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), SPRAVATO | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Neuroscience | ||||||
| 11/19/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, SPRAVATO | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Neuroscience | ||||||
| 10/22/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, SPRAVATO | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Neuroscience | ||||||
| 09/10/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 19 | 19 | $4,417 | $961.40 |
| 2022 | 1 | 20 | 20 | $4,700 | $673.97 |
| 2021 | 1 | 13 | 13 | $30,551 | $927.96 |
Total Patients
52
Total Services
52
Medicare Billing
$2,563
Procedure Codes
3
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 19 | $4,417 | $961.40 | 21.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $4,700 | $673.97 | 14.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 13 | $30,551 | $927.96 | 3.0% |
About Dr. David Estrada, MD
Dr. David Estrada, MD is a Psychiatry healthcare provider based in Norwalk, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861453722.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Estrada, MD has received a total of $1,632 in payments from pharmaceutical and medical device companies, with $59.98 received in 2024. These payments were reported across 79 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,632).
As a Medicare-enrolled provider, Estrada has provided services to 52 Medicare beneficiaries, totaling 52 services with total Medicare billing of $2,563. Data is available for 3 years (2021–2023), covering 3 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry
- Location Norwalk, CA
- Active Since 03/30/2006
- Last Updated 05/04/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1861453722
Products in Payments
- TRINTELLIX (Drug) $304.41
- INVEGA SUSTENNA (Drug) $285.06
- Adzenys XR-ODT (Drug) $237.09
- VYVANSE (Drug) $123.18
- VRAYLAR (Drug) $119.35
- QELBREE (Drug) $118.30
- LATUDA (Drug) $115.89
- REXULTI (Drug) $58.88
- ABILIFY MAINTENA (Drug) $52.48
- SPRAVATO (Drug) $45.42
- Vyvanse (Drug) $41.58
- MYDAYIS (Drug) $34.68
- INGREZZA (Drug) $26.59
- Aristada 441 mg (Drug) $23.69
- NUPLAZID (Drug) $16.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Norwalk
Bart Sloan, Md, MD
Psychiatry — Payments: $21,439
Psychiatry $21,439
Dr. Jennifer Oday, M.d, M.D
Psychiatry — Payments: $5,024
Psychiatry $5,024
Dr. Upender Gehlot, M.d, M.D
Psychiatry — Payments: $4,207
Psychiatry $4,207
John Meyers, Md, MD
Psychiatry — Payments: $3,061
Psychiatry $3,061
Dr. Laura Dardashti, Md, MD
Psychiatry — Payments: $2,869
Psychiatry $2,869
Jinous Parvizi, M.d, M.D
Psychiatry — Payments: $1,454
Psychiatry $1,454